Abstract:Human motoneuron disease is characterized by loss of motor endplates, axonal degeneration, and cell death of motoneurons. The identification of the underlying gene defects for familial ALS, spinal muscular atrophy (SMA), and spinal muscular atrophy with respiratory distress (SMARD) has pointed to distinct pathophysiological mechanisms that are responsible for the various forms of the disease. Accumulating evidence from mouse models suggests that enhanced vulnerability and sensitivity to proapoptotic stimuli is only responsible for some but not all forms of motoneuron disease. Mechanisms that modulate microtubule assembly and the axonal transport machinery are defective in several spontaneous and ENU (ethylnitrososurea) mutagenized mouse models but also in patients with mutations in the p150 subunit of dynactin. Recent evidence suggests that axonal growth defects contribute significantly to the pathophysiology of spinal muscular atrophy. Reduced levels of the survival motoneuron protein that are responsible for SMA lead to disturbed RNA processing in motoneurons. This could also affect axonal transport of mRNAs for beta-actin and other proteins that play an essential role in axon growth and synaptic function. The local translation of specific proteins might be affected, because developing motoneurons contain ribosome-like structures in distal axons and growth cones. Altogether, the evidence from these mouse models and the new genetic data from patients suggest that axon growth and maintenance involves a variety of mechanisms, including microtubule assembly and axonal transport of proteins and ribonucleoproteins (RNPs). Thus, defects in axon maintenance could play a leading role in the development of several forms of human motoneuron disease.

Defective Membrane Remodeling in Neuromuscular Diseases: Insights from Animal Models

Axonal defects in mouse models of motoneuron disease

Neuromuscular Development and Disease: Learning From in vitro and in vivo Models

Annexins and Membrane Repair Dysfunctions in Muscular Dystrophies

Deficient Sarcolemma Repair in ALS: A Novel Mechanism with Therapeutic Potential

Skeletal Muscle in Motor Neuron Diseases: Therapeutic Target and Delivery Route for Potential Treatments

Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction between MG53, Caveolin-3, and Dysferlin

Membrane Injury and Repair in the Muscular Dystrophies

Trafficking of Annexins during Membrane Repair in Human Skeletal Muscle Cells

The Myelin Mutants as Models to Study Myelin Repair in the Leukodystrophies

Molecular Myelin Dysfunction in the Most Common Inherited Peripheral Neuropathies - CMT1A and HNPP

The role of apoptosis in neuromuscular diseases and prospects for anti-apoptosis therapy

New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis

Disease Mechanisms and Therapeutic Approaches in SMARD1—Insights from Animal Models and Cell Models

[Neuroscience] Building, Breaking, and Repairing Neuromuscular Synapses

Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship?

Histopathology of Skeletal Muscle in a Distal Motor Neuropathy Associated with a Mutant CCT5 Subunit: Clues for Future Developments to Improve Differential Diagnosis and Personalized Therapy

Disruption of genes associated with Charcot-Marie-Tooth type 2 lead to common behavioural, cellular and molecular defects in Caenorhabditis elegans

Oligomerization of dynamin superfamily proteins in health and disease.

Dynein disruption perturbs post-synaptic components and contributes to impaired MuSK clustering at the NMJ: implication in ALS

Understanding Genetic Pathways, Disease Models, and Potential Therapeutic Approaches